Table 1.
Baseline Characteristics of the Patients Included in the Analysis
| Characteristics | N= 23 (100%) |
|---|---|
| Median age, years (IQR) | 23.6 (21.8–28.6) |
| Female/Male n(%) | 11 (41.8%)/12 (52.2%) |
| Performance status, n(%) | |
| 0 | 20 (86.9%) |
| 1 | 3 (13.1%) |
| Cirrhosis, n(%) | 1 (4.3%) |
| No comorbidities | 18 (78.3%) |
| Family history of cancer | 4 (17.4%) |
| Disease extent | |
| Intrahepatic unresectable | 4 (17.4%) |
| Metastatic | 19 (82.6%) |
| Liver affection | |
| Single lesion | 12 (52.2%) |
| Multinodular | 11 (47.8%) |
| Macrovascular invasion | 7 (30.7%) |
| Lung metastasis | 9 (39.1%) |
| Lymph node metastasis | 9 (39.1%) |
| Peritoneal metastasis | 5 (21.7%) |
| Bone metastasis | 1 (4.3%) |
| Previous local treatment | |
| Hepatic surgery | 15 (65.2%) |
| Ablation | 2 (8.7%) |
| SBRT | 1 (4.3%) |
| Palliative radiotherapy | 4 (17.4%) |
| Median size of the largest liver tumor, cm (IQR) | 8.8 cm (3.1–13.3) |
Abbreviations: IQR, interquartile range; SBRT, Stereotactic Body Radiotherapy.